(19)
(11) EP 4 815 949 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898900.6

(22) Date of filing: 02.12.2024
(51) International Patent Classification (IPC): 
A61K 31/485(2006.01)
A61K 9/24(2006.01)
A61P 25/24(2006.01)
 A61K 9/00(2006.01)
A61K 31/137(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/2027; A61K 31/137; A61K 31/485; A61P 25/24
 
C-Sets:
  1. A61K 31/137, A61K 2300/00;
  2. A61K 31/485, A61K 2300/00;
(86) International application number:
PCT/US2024/058092
(87) International publication number:
WO 2025/117954 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 US 202363605337 P
01.12.2023 US 202363605408 P

(71) Applicant: Antecip Bioventures II LLC
New York, NY 10111 (US)

(72) Inventor:
  • TABUTEAU, Herriot
    New York, New York 10007 (US)

(74) Representative: Murgitroyd & Company 
165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)

   


(54) COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING DEPRESSION IN PATIENTS